About
Poxel is a clinical-stage biopharmaceutical company developing drug candidates targeting metabolic diseases, including treatments for type 2 diabetes, non-alcoholic steatohepatitis (NASH), and rare metabolic disorders.
Explore Poxel's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.